高级检索
当前位置: 首页 > 详情页

The paradoxical problem with COVID-19 ocular infection: Moderate clinical manifestation and potential infection risk

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE ◇ EI

单位: [1]Southern Med Univ, Nanjing Clin Coll, Nanjing Univ, COVID 19 Res Ctr,Inst Lab Med,Jinling Hosp,Sch Me, Nanjing 210002, Jiangsu, Peoples R China [2]Nanjing Univ, Jinling Hosp, Dept Ophthalmol, Sch Med, Nanjing 210002, Jiangsu, Peoples R China [3]901th Hosp Joint Logist Support Force PLA, Dept Clin Lab, Hefei 230031, Anhui, Peoples R China [4]Taikang Tongji Hosp, Dept Clin Lab, Wuhan 430050, Hubei, Peoples R China [5]Jericho High Sch, 99 Cedar Swamp Rd, Jericho, NY 11753 USA [6]Wuhan Huoshenshan Hosp, Dept Lab Med, Joint Expert Grp COVID 19, Wuhan 430100, Hubei, Peoples R China
出处:
ISSN:

关键词: COVID-19 SARS-CoV-2 Ocular infection

摘要:
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which induced mainly the respiratory damage also caused ocular surface symptoms. However, the detailed description of ocular manifestations, severity fluctuations in confirmed COVID-19 adult patients still lacked. We analyzed onset clinical symptoms and duration, ocular symptoms, needs for medication, outcomes in 28 conjunctivitis patients who were extracted from 3198 COVID-19 patients hospitalized in Huoshenshan Hospital and Taikangtongji Hospital, Wuhan, China. The expression levels of ACE2, TMPRSS2, ANPEP, DPP4, NRP1 on fetal and adult ocular surface and mouse lacrimal glands were assessed by single cell seq analysis. Our results indicated that conjunctivitis was a rare and self-limited complication in adults with COVID-19 while the existence of coronavirus receptors on human ocular surface and mouse lacrimal glands indicated the risk of SARS-CoV-2 infection. Our research firstly examined SARS-CoV-2 receptors, including the new discovered one, NRP1, on the fetal ocular surface and in the mouse lacrimal glands. (C) 2021 The Author(s). Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 2 区 生物
小类 | 2 区 生化与分子生物学
最新[2025]版:
大类 | 3 区 生物学
小类 | 3 区 生化与分子生物学
JCR分区:
出版当年[2019]版:
Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY
最新[2023]版:
Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者单位: [1]Southern Med Univ, Nanjing Clin Coll, Nanjing Univ, COVID 19 Res Ctr,Inst Lab Med,Jinling Hosp,Sch Me, Nanjing 210002, Jiangsu, Peoples R China
通讯作者:
通讯机构: [1]Southern Med Univ, Nanjing Clin Coll, Nanjing Univ, COVID 19 Res Ctr,Inst Lab Med,Jinling Hosp,Sch Me, Nanjing 210002, Jiangsu, Peoples R China [6]Wuhan Huoshenshan Hosp, Dept Lab Med, Joint Expert Grp COVID 19, Wuhan 430100, Hubei, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:426 今日访问量:2 总访问量:410 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)